• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性活动性肝炎。基于临床和血清学研究的病因学考量

Chronic active hepatitis. Aetiological considerations based on clinical and serological studies.

作者信息

Dietrichson O

出版信息

Scand J Gastroenterol. 1975;10(6):617-24.

PMID:1179155
Abstract

The diagnosis of chronic active (aggressive) hepatitis is based mainly on characteristic morphological changes. During a 7-year period, 85 cases were diagnosed in three medical departments in Copenhagen. This material is presented by clinical, biochemical, and serological variables at the time of diagnosis. None of the patients had simultaneously occurring Australia antigen and circulating autoantibodies. A comparison between two serologically homogeneous groups revealed significant differences in sex and age distribution onset of disease, and biochemical activity. The investigation suggests the existence of aetiologically different forms of chronic active hepatitis. Some cases are apparently caused by a persistent viral infection, while others may be due to a primary autoimmune mechanism. A considerable number of the patients stated that they had had prolonged intake of the potentially hepatotoxic laxative, oxyphenisatin. Nineteen patients were challenged with the drug and eight reacted with an increased biochemical activity in the liver disease. All these patients belonged to the group with circulating autoantibodies. It is possible that oxyphenisatin may be the primary cause of the chronic liver damage in some cases.

摘要

慢性活动性(侵袭性)肝炎的诊断主要基于特征性的形态学改变。在7年期间,哥本哈根的三个医学科室诊断出85例该疾病。本文根据诊断时的临床、生化和血清学变量呈现了这些病例资料。所有患者均未同时出现澳大利亚抗原和循环自身抗体。对两个血清学特征相同的组进行比较,结果显示在性别、年龄分布、发病情况及生化活性方面存在显著差异。该调查表明存在病因不同的慢性活动性肝炎形式。一些病例显然由持续的病毒感染引起,而其他病例可能归因于原发性自身免疫机制。相当多的患者表示他们长期服用了具有潜在肝毒性的泻药奥昔芬净。19名患者接受了该药激发试验,其中8名患者肝病的生化活性增强。所有这些患者都属于循环自身抗体阳性组。在某些病例中,奥昔芬净有可能是慢性肝损伤的主要病因。

相似文献

1
Chronic active hepatitis. Aetiological considerations based on clinical and serological studies.慢性活动性肝炎。基于临床和血清学研究的病因学考量
Scand J Gastroenterol. 1975;10(6):617-24.
2
Chronic persistent hepatitis. A clinical, serological, and prognostic study.慢性持续性肝炎。一项临床、血清学及预后研究。
Scand J Gastroenterol. 1975;10(3):249-55.
3
A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.慢性丙型肝炎患者与自身免疫性肝炎患者自身抗体患病率的比较:干扰素在自身免疫性疾病发生中的作用。
Hepatogastroenterology. 1997 Mar-Apr;44(14):417-25.
4
Are the causes and presentation of chronic hepatitis changing? An analysis of 104 cases over 15 years.慢性肝炎的病因及临床表现正在发生变化吗?一项对15年间104例病例的分析。
Q J Med. 1984 Spring;53(210):279-88.
5
[Chronic aggressive active hepatitis. Etiologic considerations based on clinical and serological studies].[慢性侵袭性活动性肝炎。基于临床和血清学研究的病因学考量]
Ugeskr Laeger. 1975 Aug 4;137(32):1820-5.
6
Clinical and immunological findings in hepatitis B antigen-positive and hepatitis B antigen-negative chronic active hepatitis.乙肝抗原阳性和乙肝抗原阴性慢性活动性肝炎的临床及免疫学发现
Acta Med Acad Sci Hung. 1975;32(1):15-25.
7
Hepatitis with Australia antigenemia following renal transplantation.肾移植后伴有澳大利亚抗原血症的肝炎
Can Med Assoc J. 1973 Jan 6;108(1):43-50.
8
[Autoantibodies and HBAg antigenemia in chronic persistent and chronic aggressive hepatitis].
Pol Tyg Lek. 1975 Nov 17;30(46):1905-8.
9
[Immunologic evaluations during prolonged and chronic hepatitis. Significance for diagnosis and prognosis. 100 cases].[长期和慢性肝炎的免疫学评估。对诊断和预后的意义。100例]
Nouv Presse Med. 1976 Nov 6;5(37):2440-3.
10
[Immunoglobulins, autoantibodies and Australia antigen in chronic hepatitis].[慢性肝炎中的免疫球蛋白、自身抗体及澳大利亚抗原]
Rev Clin Esp. 1974 Sep 30;134(6):553-7.

引用本文的文献

1
Drug-induced chronic hepatitis.药物性慢性肝炎
Springer Semin Immunopathol. 1980 Dec;3(3):331-8. doi: 10.1007/BF02054108.